Phase II trials of zilucoplan in paroxysmal nocturnal hemoglobinuria.
Saved in:
| Title: | Phase II trials of zilucoplan in paroxysmal nocturnal hemoglobinuria. |
|---|---|
| Authors: | Kulasekararaj AG; King's College Hospital-NHS Foundation Trust, NIHR/Wellcome King's Clinical Research Facility, London, UK and King's College London, London., Lehtinen AE; Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki, Helsinki., Forsyth C; Gosford Hospital, Gosford, NSW., Gandhi S; King's College Hospital-NHS Foundation Trust, NIHR/Wellcome King's Clinical Research Facility, London, UK and King's College London, London., Griffin M; St. James's University Hospital, Leeds., Körper S; University of Ulm, Institute of Transfusion Medicine, and Institute of Transfusion Medicine and Immunogenetics Ulm, Red Cross Blood Transfusion Service Baden-Württemberg-Hessen and University Hospital Ulm, Ulm., Mikala G; Central Hospital of Southern Pest National Institute of Hematology and Infectious Diseases, Budapest., Muus P; King's College Hospital-NHS Foundation Trust, NIHR/Wellcome King's Clinical Research Facility, London, UK and King's College London, London, UK; St. James's University Hospital, Leeds., Overgaard U; University Hospital Copenhagen, Copenhagen, Denmark., Patriquin CJ; University Health Network, Toronto, ON., Pullon H; Waikato Hospital, Hamilton., Shen YM; UT Southwestern Medical Center, Dallas, TX., Spearing R; Christchurch Hospital, Christchurch., Szer J; Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC., De la Borderie G; Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC., Duda PW; UCB Pharma, Cambridge, MA., Farzaneh-Far R; UCB Pharma, Cambridge, MA., Ragunathan S; UCB Pharma, Cambridge, MA., Sayegh CE; UCB Pharma, Cambridge, MA., Vadysirisack DD; UCB Pharma, Cambridge, MA., Schrezenmeier H; University of Ulm, Institute of Transfusion Medicine, and Institute of Transfusion Medicine and Immunogenetics Ulm, Red Cross Blood Transfusion Service Baden-Württemberg-Hessen and University Hospital Ulm, Ulm. h.schrezenmeier@blutspende.de. |
| Source: | Haematologica [Haematologica] 2024 Mar 01; Vol. 109 (3), pp. 929-935. Date of Electronic Publication: 2024 Mar 01. |
| Publication Type: | Clinical Trial, Phase II; Letter; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
